Cheng-Chung Wu

Factors Influencing Postoperative Morbidity, Mortality, and Survival After Resection for Hilar Cholangiocarcinoma

Cheng‐Hsi Su, Shyh‐Haw Tsay, Cheng-Chung Wu et al. · Annals of Surgery · 1996 · 299 citations

Medicine, Oncology, Surgery +14

A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer

J.S. Chen, Chih‐Hung Hsu, Nai‐Jung Chiang et al. · Annals of Oncology · 2015 · 158 citations

Medicine, Oncology, Cancer Genetics +10

Perioperative Parenteral Tranexamic Acid in Liver Tumor Resection

Cheng-Chung Wu, Wai‐Meng Ho, Shao‐Bin Cheng et al. · Annals of Surgery · 2006 · 141 citations · Full text

Medicine, Perioperative Medicine, Surgery +15

Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan

Sheng‐Nan Lu, Jing‐Houng Wang, Chien‐Wei Su et al. · Journal of the Formosan Medical Association · 2017 · 119 citations · Full text

Medicine, Oncology, Surgery +13

Detection of the Hepatitis B Virus X Protein (HBx) Antigen and Anti-HBx Antibodies in Cases of Human Hepatocellular Carcinoma

Guang‐Yuh Hwang, Chuang-Yu Lin, Limei Huang et al. · Journal of Clinical Microbiology · 2003 · 77 citations · Full text

Medicine, Biochemistry, Molecular Biology +16